These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21637021)

  • 1. Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection.
    Watanabe T; Asano N; Kitani A; Fuss IJ; Chiba T; Strober W
    Gut Microbes; 2011; 2(1):61-5. PubMed ID: 21637021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIFA Signaling in Gastric Epithelial Cells Initiates the
    Gall A; Gaudet RG; Gray-Owen SD; Salama NR
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811347
    [No Abstract]   [Full Text] [Related]  

  • 3. NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells.
    Tran LS; Tran D; De Paoli A; D'Costa K; Creed SJ; Ng GZ; Le L; Sutton P; Silke J; Nachbur U; Ferrero RL
    Cell Microbiol; 2018 May; 20(5):e12826. PubMed ID: 29392836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide-binding oligomerization domain 1 and
    Minaga K; Watanabe T; Kamata K; Asano N; Kudo M
    World J Gastroenterol; 2018 Apr; 24(16):1725-1733. PubMed ID: 29713127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity.
    Allison CC; Ferrand J; McLeod L; Hassan M; Kaparakis-Liaskos M; Grubman A; Bhathal PS; Dev A; Sievert W; Jenkins BJ; Ferrero RL
    J Immunol; 2013 Apr; 190(7):3706-15. PubMed ID: 23460743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.
    Watanabe T; Asano N; Fichtner-Feigl S; Gorelick PL; Tsuji Y; Matsumoto Y; Chiba T; Fuss IJ; Kitani A; Strober W
    J Clin Invest; 2010 May; 120(5):1645-62. PubMed ID: 20389019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders.
    Watanabe T; Asano N; Kudo M; Strober W
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(8):578-599. PubMed ID: 29021509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel epidermal growth factor receptor pathway mediates release of human β-defensin 3 from Helicobacter pylori-infected gastric epithelial cells.
    Muhammad JS; Zaidi SF; Zhou Y; Sakurai H; Sugiyama T
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26733497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
    Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection.
    Ying L; Ferrero RL
    Curr Top Microbiol Immunol; 2019; 421():159-177. PubMed ID: 31123889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori on gastric epithelial cells.
    Alzahrani S; Lina TT; Gonzalez J; Pinchuk IV; Beswick EJ; Reyes VE
    World J Gastroenterol; 2014 Sep; 20(36):12767-80. PubMed ID: 25278677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.
    Morey P; Pfannkuch L; Pang E; Boccellato F; Sigal M; Imai-Matsushima A; Dyer V; Koch M; Mollenkopf HJ; Schlaermann P; Meyer TF
    Gastroenterology; 2018 Apr; 154(5):1391-1404.e9. PubMed ID: 29273450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.
    Asano N; Imatani A; Watanabe T; Fushiya J; Kondo Y; Jin X; Ara N; Uno K; Iijima K; Koike T; Strober W; Shimosegawa T
    Cancer Res; 2016 Mar; 76(5):1135-45. PubMed ID: 26759244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune and inflammatory reaction to Helicobacter pylori in the stomach].
    Wakatsuki Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():150-5. PubMed ID: 16363522
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children.
    Krauss-Etschmann S; Gruber R; Plikat K; Antoni I; Demmelmair H; Reinhardt D; Koletzko S
    Helicobacter; 2005 Jun; 10(3):214-22. PubMed ID: 15904479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism.
    Allison CC; Kufer TA; Kremmer E; Kaparakis M; Ferrero RL
    J Immunol; 2009 Dec; 183(12):8099-109. PubMed ID: 20007577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune evasion strategies used by Helicobacter pylori.
    Lina TT; Alzahrani S; Gonzalez J; Pinchuk IV; Beswick EJ; Reyes VE
    World J Gastroenterol; 2014 Sep; 20(36):12753-66. PubMed ID: 25278676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen
    Suarez G; Romero-Gallo J; Piazuelo MB; Sierra JC; Delgado AG; Washington MK; Shah SC; Wilson KT; Peek RM
    Cancer Res; 2019 Apr; 79(7):1600-1611. PubMed ID: 30696658
    [No Abstract]   [Full Text] [Related]  

  • 20. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.